justbacked

Biotechnology, Medical

Transcripta Bio

Transcripta Bio raised $24M in a Series A announced on Jul 22, 2026, led by Gaingels, Mayo Clinic, BlueYard Capital, Jazz Venture Partners, Omnimed Capital. Since then it has posted 3 roles (2 still open), the first 113 days after it. With 2 open roles it is hiring more than 4% of the 226 Series A startups on JustBacked (median: 9). In total it has raised $34.4M over 3 rounds from 5 investors.

Transcripta Bio is a company that focuses on drug development at a size and pace never seen before, with a lower risk.

Why join Transcripta Bio?

Profiling every gene in every cell is no longer a research luxury, and Transcripta Bio, a Palo Alto biotech, could turn that into a way to match disease signatures to the drugs that reverse them. Its $24M Series A from Mayo Clinic, BlueYard Capital and Jazz Venture Partners follows $34M raised over three rounds. Two science roles opened in the last 30 days, so early hires will shape how the platform gets built.

JustBacked's take, based on Transcripta Bio's own site and its funding and hiring data.

Series A · $24M · 122d agotranscriptabio.com

Hiring velocity

Open roles
2
Added, 30 days
+2
Added, 7 days
+0
Closed, 30 days
1
Raised
122 days ago
Led by
Gaingels, Mayo Clinic, BlueYard Capital, Jazz Venture Partners, Omnimed Capital
Team size
11-50
HQ
Palo Alto, California, United States
Newest role
7d ago
Tracked since
Nov 12, 2026

Where they're hiring

Science2

Open roles at Transcripta Bio

$24M · 122d ago

Transcripta Bio · Series A

Lab Manager

Palo Alto, CA

$100K–$105K

Posted 7 days ago· Nov 13

ScienceLed by Gaingels, Mayo Clinic

Source: transcriptabio.com, checked daily.